Cost-effectiveness of pessary therapy versus surgery for symptomatic pelvic organ prolapse: an economic evaluation alongside a randomised non-inferiority controlled trialÂngela J Ben, Lisa R van der Vaart, Judith E. Bosmans, Jan-Paul W R Roovers, Antoinette L M Lagro-Janssen, Carl H van der Vaart, Astrid Vollebregt, , PEOPLE group, F Milani, G G Bon, M Y Bongers, K Bos, A M W Broekman, V DietzSee the full list of authors
1 May 2024
Cost analysis for initiating an integrated package of essential non-communicable disease interventions (PEN-Plus) in Kondoa District Hospital, Tanzania: a time-driven activity-based costing (TDABC) study protocolHarrieth Peter Ndumwa, Amani Thomas Mori, George Mugambage Ruhago, Ritha Willilo, Ryan McBain, Chantelle Boudreaux, Emily Wroe, Alma J Adler, Gene Bukhman, Mary Theodory Mayige, Oddvar Kaarboe
1 May 2024
Lifetime costs of alcohol consumption in Thailand: protocol for an incidence-based cost-of-illness study using Markov modelChaisiri Luangsinsiri, Montarat Thavorncharoensap, Usa Chaikledkaew, Oraluck Pattanaprateep, Bundit Sornpaisarn, Jürgen Rehm
29 April 2024
Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trialWilliam King, Tara Homer, Chris Harding, Helen Mossop, Thomas Chadwick, Alaa Abouhajar, Luke Vale
29 April 2024
Learning motivation and self-assessment in health economics: a survey on overconfidence in healthcare providersStefan Bushuven, Michael Bentele, Milena Trifunovic-Koenig, Bianka Gerber, Stefanie Bentele, Fritz Hagen, Oliver Schoeffski, Hartwig Marung, Reinhard Strametz
28 April 2024
Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experimentAlistair Bullen, Mandy Ryan, Holly Ennis, Ewan Gray, Luis Enrique Loría-Rebolledo, Morag McIntyre, Peter Hall
28 April 2024
Impact of an ICU bed capacity optimisation method on the average length of stay and average cost of hospitalisation following implementation of China’s open policy with respect to COVID-19: a difference-in-differences analysis based on information management system data from a tertiary hospital in southwest ChinaQingyan Zheng, Zhongyi Zeng, Xiumei Tang, Li Ma
19 April 2024
Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines)Megan A Hansen, Nkgomeleng A Lekodeba, Joshua M Chevalier, Tom Ockhuisen, Paula del Rey-Puech, Elena Marban-Castro, Guillermo Zohar Martínez-Pérez, Sonjelle Shilton, Muhammad Radzi Abu Hassan, Vladimir Getia, Catiuscia Weinert-Mizuschima, Maria Isabelle Tenorio Bezerra, Lensa Chala, Robert Leong, Remilekun PereginoSee the full list of authors
17 April 2024
Cost-effectiveness of a radio intervention to stimulate early childhood development: protocol for an economic evaluation of the SUNRISE trial in Burkina FasoTom Palmer, Abbie Clare, Pasco Fearon, Roy Head, Zelee Hill, Bassirou Kagone, Betty Kirkwood, Alexander Manu, Jolene Skordis,
16 April 2024
Scaling hypertension treatment in 24 low-income and middle-income countries: economic evaluation of treatment decisions at three blood pressure cut-pointsBrian Hutchinson, Adam Walter, Norm Campbell, Paul K Whelton, Cherian Varghese, Muhammad Jami Husain, Rachel Nugent, Deliana Kostova, Amanda Honeycutt
15 April 2024
